These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 7753801)

  • 1. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.
    Tennent GA; Lovat LB; Pepys MB
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4299-303. PubMed ID: 7753801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of amyloid proteins.
    Benson MD; Kluve-Beckerman B; Liepnieks JJ; Murrell JR; Hanes D; Uemichi T
    Ciba Found Symp; 1996; 199():104-13; discussion 113-8. PubMed ID: 8915606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous serum amyloid P component-deficiency does not enhance regression of AA amyloid deposits.
    Usui I; Kawano H; Ito S; Hamada Y; Ishihara T; Maeda S
    Amyloid; 2001 Jun; 8(2):101-4. PubMed ID: 11409030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloidosis.
    Tan SY; Pepys MB
    Histopathology; 1994 Nov; 25(5):403-14. PubMed ID: 7868080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloidosis: new strategies for treatment.
    Hirschfield GM; Hawkins PN
    Int J Biochem Cell Biol; 2003 Dec; 35(12):1608-13. PubMed ID: 12962700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs.
    Pepys MB
    Front Immunol; 2018; 9():2382. PubMed ID: 30459761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission of systemic AA amyloidosis in animals.
    Murakami T; Ishiguro N; Higuchi K
    Vet Pathol; 2014 Mar; 51(2):363-71. PubMed ID: 24280941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AA amyloid fibrils from diseased tissue are structurally different from in vitro formed SAA fibrils.
    Bansal A; Schmidt M; Rennegarbe M; Haupt C; Liberta F; Stecher S; Puscalau-Girtu I; Biedermann A; Fändrich M
    Nat Commun; 2021 Feb; 12(1):1013. PubMed ID: 33579941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
    Coria F; Castaño EM; Frangione B
    Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum amyloid P component enhances induction of murine amyloidosis.
    Togashi S; Lim SK; Kawano H; Ito S; Ishihara T; Okada Y; Nakano S; Kinoshita T; Horie K; Episkopou V; Gottesman ME; Costantini F; Shimada K; Maeda S
    Lab Invest; 1997 Nov; 77(5):525-31. PubMed ID: 9389795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis and biochemistry of amyloidosis.
    Cohen AS; Connors LH
    J Pathol; 1987 Jan; 151(1):1-10. PubMed ID: 3550020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloidosis: a review of recent diagnostic and therapeutic developments.
    Gillmore JD; Hawkins PN; Pepys MB
    Br J Haematol; 1997 Nov; 99(2):245-56. PubMed ID: 9375734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of heating on the stability of amyloid A (AA) fibrils and the intra- and cross-species transmission of AA amyloidosis.
    Ogawa S; Murakami T; Inoshima Y; Ishiguro N
    Amyloid; 2015; 22(4):236-43. PubMed ID: 26588017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senile systemic amyloidosis.
    Pitkänen P; Westermark P; Cornwell GG
    Am J Pathol; 1984 Dec; 117(3):391-9. PubMed ID: 6507586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of fibrillogenesis and the protective role of amyloid P component: two possible avenues for therapy.
    Pepys MB; Tennent GA; Booth DR; Bellotti V; Lovat LB; Tan SY; Persey MR; Hutchinson WL; Booth SE; Madhoo S; Soutar AK; Hawkins PN; Van Zyl-Smit R; Campistol JM; Fraser PE; Radford SE; Robinson CV; Sunde M; Serpell LC; Blake CC
    Ciba Found Symp; 1996; 199():73-81; discussion 81-9. PubMed ID: 8915605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amyloidosis; pathogenesis and therapy].
    Witteman EM; Janssen HL; Hazenberg BP; Janssen S
    Ned Tijdschr Geneeskd; 1992 Nov; 136(47):2318-22. PubMed ID: 1461301
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
    Pepys MB
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
    Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA
    J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse senile amyloidosis. ASSAM amyloidosis in mice presents universally as a systemic age-associated amyloidosis.
    Higuchi K; Naiki H; Kitagawa K; Hosokawa M; Takeda T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(4):231-8. PubMed ID: 1681611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human lysozyme inhibits the fibrillation of serum amyloid a protein from systemic AA amyloidosis.
    Moderer T; Puşcalău-Gîrţu I; Haupt C; Baur J; Rodríguez-Alfonso A; Wiese S; Schmidt CQ; Malešević M; Forssmann WG; Ständker L; Fändrich M
    Amyloid; 2023 Dec; 30(4):424-433. PubMed ID: 37431668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.